Shenfu injection for heart failure based on the AMSTAR-2, PRISMA, and GRADE tools
Author(s) -
Liuying Li,
Shao Yin,
Taijun Jiang,
Zimeng Li,
Gang Zheng,
Shumin Chen,
Fengya Zhu
Publication year - 2021
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-21-1073
Subject(s) - medicine , observational study , cochrane library , systematic review , quality of evidence , randomized controlled trial , meta analysis , grading (engineering) , quality assessment , medline , medical physics , pathology , external quality assessment , engineering , civil engineering , political science , law
Evidence of the efficacy of Shenfu injection (SFI) in the treatment of heart failure (HF) is inconsistent. This study aimed to strictly evaluate the methodological quality, reporting quality, and evidence quality of systematic reviews (SRs) and meta-analyses (MAs) on the efficacy of SFI.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom